Understanding the Psychosocial Needs of Parents Who Have Lost a Child to Cancer
Sponsor: Dana-Farber Cancer Institute
A observational or N/A phase clinical study on Parents Who Have Lost a Child to Cancer, this trial is ongoing. The trial is conducted by Dana-Farber Cancer Institute and has accumulated 16 data snapshots since 2009. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
16 versions recorded-
Apr 21, 2026 — Present [daily]
Active Not Recruiting
-
Oct 2025 — Apr 2026 [monthly]
Active Not Recruiting
-
Oct 2024 — Oct 2025 [monthly]
Active Not Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
▶ Show 11 earlier versions
-
Oct 2023 — Jul 2024 [monthly]
Active Not Recruiting
-
Jun 2023 — Oct 2023 [monthly]
Active Not Recruiting
-
Jul 2022 — Jun 2023 [monthly]
Active Not Recruiting
-
Sep 2021 — Jul 2022 [monthly]
Active Not Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting
-
Jul 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Jul 2019 — Jul 2020 [monthly]
Active Not Recruiting
-
Jul 2018 — Jul 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
First recorded
Aug 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
The purpose of this study is to understand the experiences and needs of parents who have lost a child to cancer. This will aid us in developing an intervention that may help parents cope with their loss.
Contact Information
- Dana-Farber Cancer Institute
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
- Ohio State University
- University of Memphis
- University of Southern California
For direct contact, visit the study record on ClinicalTrials.gov .